The Affordable Prescriptions for Patients Act amends patent law to address infringement of patents related to biological products.

The Affordable Prescriptions for Patients Act amends title 35, United States Code, to address the infringement of patents that claim biological products. It specifies conditions under which a patent infringement action can be brought against an applicant for approval of a biological product. The act also limits the number of patents that can be asserted in such actions and provides criteria for increasing this limit. The changes apply to applications submitted under the Public Health Service Act on or after the enactment of this Act.

The Affordable Prescriptions for Patients Act amends patent law to address infringement of patents related to biological products.

The Affordable Prescriptions for Patients Act amends title 35, United States Code, to address the infringement of patents that claim biological products. It specifies conditions under which a patent infringement action can be brought against an applicant for approval of a biological product. The act also limits the number of patents that can be asserted in such actions and provides criteria for increasing this limit. The changes apply to applications submitted under the Public Health Service Act on or after the enactment of this Act.